By enhancing NF‐κB and IRF3 activity, RNF114 boosts the production of IFN‐I, suggesting that its genetic dysregulation in psoriasis contributes to pathogenesis by driving excessive inflammatory cytokine production in the skin [382]. This evidence concerns the gene RNF114 and psoriasis.